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Abstract
A tendency to an increase in migration times was observed when different water-soluble vitamins were analysed
repeatedly in pharmaceutical preparations by capillary electrophoresis. In order to better understand the origin of this effect,
the influence of the vitamins and the excipients, such as cellulose derivatives, was investigated. These studies indicated that
the increase in analyte migration times was most probably due to the adsorption of different kinds of constituents to the
capillary wall. Different rinsing procedures were tested in order to eliminate these unfavourable effects. A rinse of the
capillary with a 25 mM sodium dodecyl sulfate (SDS) solution in the running buffer between successive runs was found to
be particularly effective when the analysis was performed by free solution capillary zone electrophoresis (CZE). When the
vitamins were determined by micellar electrokinetic chromatography (MEKC) using SDS as surfactant, a short capillary
rinse with the running buffer was sufficient to obtain reproducible migration times. The CZE and MEKC methods developed
were validated and compared. Both methods could be applied to the determination of water-soluble vitamins in different
multivitamin formulations. Ó 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction 13,17], injections [2], syrup and gelatine capsules
[12,16], using free solution capillary zone electro-
Vitamins are available in many pharmaceutical phoresis (CZE) [11–12,14,16–17], micellar electro-
formulations (multivitamin preparations), most of kinetic chromatography (MEKC) [1–4,6–7,12–
them containing various kinds of excipients. Conse- 13,17] or microemulsion electrokinetic capillary
quently, the quality control of these complex prepa- chromatography (MEEKC) [15].
rations needs high resolution separation techniques. One of the problems often met in the CE de-
The use of capillary electrophoresis (CE) for de- termination of vitamins and other pharmaceuticals in
termination of vitamins has been widely described tablets is a progressive increase in analyte migration
[1–17]. times related to a decrease of the electroosmotic flow
Vitamins were determined in different kinds of velocity [11,12,17]. Furthermore, since in CE, the
pharmaceutical formulations, such as tablets [6,10– peak area of an analyte is directly related to its
migration time [18,19], any variability in migration
times will be reflected in peak areas leading to poor
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the corresponding migration time (peak area nor- min C) and calcium pantothenate (vitamin B5) were
malisation) [18–20]. Besides, several authors provided by SMB Technology (Marche-en-Famenne,
[12,21–24] have suggested the use of an internal Belgium). All solutions were filtered through a 0.22-
¨standard to increase the precision of quantitative mm cellulose acetate membrane (Sartorius, Gotting-
results. en, Germany) before use.
In a previous work [17], we have shown the
necessity, in some cases, of the simultaneous use of 2.3. Electrophoretic technique
peak area normalisation and internal standardisation
to improve method precision. Electrophoretic separations were carried out with
In this paper, the influence of active ingredients uncoated fused-silica capillaries of 48.5 cm (40 cm
and excipients in pharmaceutical formulations on to the detector)350 mm I.D. (Hewlett-Packard, Palo
migration time drift has been studied. Alto, CA, USA). Before initial use, the capillary was
Rinsing sequences in which running buffer con- washed successively with basic solutions (i.e., 1 M
taining sodium dodecyl sulfate (SDS) was involved NaOH followed by 0.1 M NaOH), water and running
have been investigated. Two CE methods for the buffer. At the beginning of each working day, the
determination of water-soluble vitamins using a capillary was washed with separation buffer for 10
buffer containing SDS either as rinsing liquid (CZE) min. The latter consisted of 0.05 M sodium tetra-
or as running buffer (MEKC) have been validated borate (borax) adjusted to pH 8.5 with boric acid for
and compared. the CZE method and 0.05 M sodium tetraborate
Finally, these two methods have been applied to (borax) adjusted to pH 8.5 with boric acid containing
the analysis of commercial multivitamin prepara- 25 mM of SDS for the MEKC method. The applied
tions. voltage was 25 kV and UV detection was performed
at 225 nm for thiamine, riboflavin, nicotinamide and
ascorbic acid, and at 215 nm for pyridoxine and
2. Experimental pantothenic acid. Injections were made using the
hydrodynamic mode (1 kPa for 10 s). The capillary
2.1. Apparatus was thermostated at 258C.
All experiments were performed using a Model 2.4. Sample preparation
3DCE system (Hewlett-Packard, Waldbronn, Ger-
many) equipped with a diode array detection system Using the same proportions of the six water
(DAD), an automatic injector, an autosampler and a soluble-vitamins as those in the pharmaceutical
temperature control system (15–608C, 60.18C). The formulation investigated, standard solutions were
3DHP CE CHEMSTATION software was used for instru- first prepared for each calibration level (n55) by
ment control, data acquisition and data analysis. The dissolving all vitamins in a 100-ml volumetric flask
pH of the buffers was adjusted by means of a Delta protected from light and with 50 ml of a 1% acetic
345 pH meter (Mettler, Healstead, UK). acid solution containing 10 mM L-cysteine (anti-
oxidant) as dissolution medium. After heating at
2.2. Chemicals and reagents 658C and shaking for 10 min, a 5-ml volume of the
internal standard solution was added to the volu-
Sodium tetraborate, L-cysteine, nicotinic acid and metric flask, unless otherwise stated. The latter was
sodium dodecyl sulfate were obtained from Sigma filled to the mark with the dissolution medium after
(St. Louis, MO, USA). Boric acid was purchased cooling to room temperature. The stock solution of
from Merck (Darmstadt, Germany). Water was of internal standard was prepared by dissolving 300 mg
Milli-Q quality (Millipore, Bedford, MA, USA). of nicotinic acid in 50 ml of the same dissolution
Thiamine mononitrate (vitamin B1), riboflavin (vita- medium. All aqueous standard solutions were then
min B2), nicotinamide (vitamin B3 or PP), pyridox- filtered through a 0.22-mm cellulose acetate mem-
ine hydrochloride (vitamin B6), ascorbic acid (vita- brane. Before dilution (from 4 to 12 times) in order
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to reach the desired concentration levels for each ine hydrochloride (7.2 mg), riboflavin (4.8 mg) and
vitamin in the calibration range (50 to 150% of the thiamine mononitrate (5.4 mg). This formulation
nominal concentrations in the pharmaceutical formu- also contained the followed excipients: cellulose,
lation studied), the resulting standard solution con- silica dioxide, magnesium stearate, stearic acid,
tained 12.52 mg/ml of ascorbic acid, 3.32 mg/ml of povidone, starch, lactose, methylhydroxypropylcel-
nicotinamide, 1.18 mg/ml of pantothenic acid, 0.44 lulose, polysorbate 60, paraffin, SDS and opaspray
mg/ml of pyridoxine, 0.30 mg/ml of riboflavin and solution (mixture of titane dioxide, hydroxypropyl-
0.33 mg/ml of thiamine. The migration order of the cellulose, yellow orange in water) for a total tablet
vitamins was determined by injecting diluted solu- mass of about 800 mg.
tions of each vitamin (six times lower concentrations
than those mentioned above) and by spectral com-
parison. 3. Results and discussion
The same sample preparation procedure was ap-
plied to synthetic mixtures of the dosage form 3.1. Influence of analytes and excipients on
excipients (analytical placebos) to which the six migration time drift
vitamins were added in the same proportions as in
the pharmaceutical formulation for some experi- With three new capillaries from the same batch
ments. and the same running buffer, three series of experi-
The multivitamin formulation (tablet) examined in ments were performed in order to better understand
this paper contained the six vitamins in the following the origin of the migration time drift. On the first
amounts: ascorbic acid (180.0 mg), nicotinamide capillary, 50 consecutive injections of a mixture of
(54.0 mg), calcium pantothenate (19.5 mg), pyridox- the six water-soluble vitamins in the same pro-
Fig. 1. Changes in migration times with the number of injections (vitamins without excipients: series A). Buffer: 50 mM borax adjusted to
pH 8.5 with boric acid. Rinsing sequence: water for 8 min and running buffer for 3 min. Other conditions as described in Section 2.
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portions as in the pharmaceutical formulation were derivatives. During successive runs, these com-
performed (Series A, Fig. 1). Between two runs, the pounds are likely to be adsorbed on the capillary
capillary was rinsed with water for 8 min and wall, leading to a progressive decrease of the electro-
running buffer for 3 min. With the second capillary, osmotic flow and consequently to an increase in
50 consecutive injections of a mixture of the six migration times.
water-soluble vitamins and the excipients in the same The variation of migration times is also different
proportions as in the pharmaceutical formulation for the two series (fairly linear with increasing
were performed under the same operating conditions number of injections for series A and with several
as for series A (Series B, Fig. 2). In series A, an steps for series B).
increase of migration times was observed, most
probably due to the presence of the positively 3.2. Determination of six water-soluble vitamins in
charged thiamine which is likely to interact with the a pharmaceutical formulation
anionic silanol groups on the capillary surface.
Indeed, after 50 consecutive injections on the third Using the CZE method [17], several rinsing
capillary of a mixture of the water-soluble vitamins sequences for reconditioning the capillary between
except thiamine and without excipients, no signifi- successive injections, involving running buffer to
cant migration time drift was obtained (Series C, Fig. which 25 mM of SDS was added, water and running
3). In comparison with series A, the increase in buffer with different rinse times, were tested in order
migration times observed with series B was clearly to improve the repeatability of migration times. As
more pronounced (Figs. 1 and 2). Among the can be seen in Table 1, acceptable RSD values were
excipients present in the pharmaceutical formulation, only obtained when the rinsing sequence involved
some are soluble in aqueous media, such as cellulose the buffer containing SDS. RSD values lower than
Fig. 2. Changes in migration times with the number of injections (vitamins with excipients: series B). Buffer: 50 mM borax adjusted to pH
8.5 with boric acid. Rinsing sequence: water for 8 min and running buffer for 3 min. Other conditions as described in Section 2.
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Fig. 3. Changes in migration times with the number of injections (vitamins except thiamine and without excipients: series C). Buffer: 50
mM borax adjusted to pH 8.5 with boric acid. Rinsing sequence: water for 8 min and running buffer for 3 min. Other conditions as described
in Section 2.
Table 1
aCZE: influence of rinsing with buffer containing SDS on migration times repeatability (RSD%) (n510)
Rinsing sequence Thiamine Nicotinamide Riboflavin Pyridoxine Ascorbic Pantothenic
(rinse time in min) acid acid
Water (4) 5.00 7.10 10.50 13.50 18.40 19.10
Buffer (1)
Buffer with SDS (3) 0.33 0.43 0.37 0.02 0.33 0.07
Water (1)
Buffer (1)
Buffer with SDS (1) 0.33 0.40 0.30 0.17 0.61 0.53
Water (1)
Buffer (1)
Buffer with SDS (1) 0.33 0.36 0.27 0.04 0.29 0.13
Buffer (1)
a Buffer: 50 mM borax adjusted to pH 8.5 with boric acid; buffer with SDS: 50 mM borax adjusted to pH 8.5 with boric acid, containing
25 mM SDS; other conditions as described in Section 2.
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Table 2
aMEKC: migration times repeatability (RSD %) (n510)
Rinsing sequence Thiamine Nicotinamide Riboflavin Pyridoxine Ascorbic Pantothenic
(rinse time in min) acid acid
Running buffer (2) 0.80 0.40 0.45 0.42 0.33 0.50
a Running buffer: 50 mM borax adjusted to pH 8.5 with boric acid, containing 25 mM SDS; other conditions as described in Section 2.
0.4% were found with a rinsing sequence consisting 3.3. Method validation
of buffer with 25 mM of SDS for 1 min, followed by
running buffer for 1 min. The latter sequence was 3.3.1. Selectivity
selected for further experiments. The introduction of Selectivity represents the ability to assess the lack
water to the rinsing sequence was found to be of interference originating from others substances
superfluous (Table 1). With the MEKC method [17], present in the matrix. As can be seen from Fig. 4
a rinse with the running buffer which already (CZE method) and Fig. 5 (MEKC method), no
contained SDS, for 2 min led to RSD values lower interference from the formulation excipients was
than 0.8% after ten successive injections (Table 2), observed at the migration times of the six vitamins to
which were considered satisfactory. be determined. The peak homogeneity was con-
Due to the good repeatability of migration times, firmed for each vitamin by use of DAD. For each
peak area normalisation (PN) was found to be compound, the comparison of various spectra re-
unnecessary under the conditions selected. As shown corded during the passage of the corresponding peak
in Table 3, results obtained for the different vitamins through the detection window led to match scores
in the pharmaceutical formulation in A and B on one very close (.990) to the maximum values [25].
hand, and in C and D on the other hand, are entirely
comparable (the only difference between these series 3.3.2. Linearity
is the use of PN in B and in D). However, the use of A linear relationship was evaluated over the
an internal standard (I.S.) was still useful. Indeed, concentration range of the analytical procedure. For
some differences can be observed between the results this purpose, calibration curves were constructed at
obtained in A and C on one hand and in B and D on five concentration levels in the range from 50 to
the other hand, the results in C and D being slightly 150% of the nominal concentration and three in-
superior to those in A and B (the only difference dependent determinations were performed at each
between these series is the use of I.S. in C and D). concentration (n53). Regression lines were obtained
Consequently, conditions for quantification in C (no by plotting the ratios of analyte peak area to that of
PN and I.S.) were selected and used in validation the internal standard ( y, arbitrary units) versus the
experiments. analyte concentration (x, mg/ml) using the least
Table 3
aPercentage of the labelled amounts obtained in a multivitamin formulation by the CZE method
Percentage labelled amounts
A B C D
Thiamine 98.862.2 99.161.7 101.760.9 101.761.3
Riboflavin 93.762.3 94.162.2 96.962.4 96.861.9
Nicotinamide 97.261.5 97.561.9 100.460.6 100.361.0
Pantothenic acid 98.461.6 99.361.8 101.061.0 101.161.6
Pyridoxine 96.462.0 96.861.6 99.261.2 99.261.3
Ascorbic acid 95.561.1 95.861.5 98.660.7 98.760.9
a Buffer: 50 mM borax adjusted to pH 8.5 with boric acid. Other conditions as described in Section 2; (A) no PN and no I.S.; (B) PN and
no I.S.; (C) no PN and I.S.; (D) PN and I.S.; PN: peak area normalisation; I.S.: internal standard (nicotinic acid).
L. Fotsing et al. / J. Chromatogr. A 853 (1999) 391 –401 397
Fig. 4. CZE separation of six vitamins in a pharmaceutical formulation Buffer: 50 mM borax adjusted to pH 8.5 with boric acid. Rinsing
sequence: buffer with 25 mM of SDS for 1 min and running buffer for 1 min. Detection wavelength: 215 nm. Other conditions as described
in Section 2.
squares method. The linearity of the calibration concentration range considered (homoscedasticity
curves for the six vitamins in aqueous solutions hypothesis). The validity of this hypothesis was
(standard solutions) was first assessed. For each confirmed by use of Cochran’s test [26,27]. The
vitamin, the relationship between response and con- adequacy of the model was then assessed by use of a
centration was found to be linear in the concentration lack of fit test, the F values obtained being lower
range considered. In all cases, straight lines passing than the critical F value of the table [26,27].
through the origin with coefficients of determination The same statistical approach was then applied to
2(r ) higher than 0.999 were obtained. However, the a synthetic mixture of the excipients of the dosage
application of the usual least squares model implies form to which known quantities of each vitamin
that the variance of the response is constant over the were added (spiked placebos), corresponding to the
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Fig. 5. MEKC separation of six vitamins in a pharmaceutical formulation. Buffer: 50 mM borax adjusted to pH 8.5 with boric acid
containing 25 mM of SDS. Rinsing sequence: running buffer for 2 min. Detection wavelength: 215 nm. Other conditions as described in
Section 2.
different concentration levels in the range tested. The confirmed by an analysis of variance (ANOVA) test.
regression parameters are given in Table 4 (CZE) The adequacy of the selected regression model to
and Table 5 (MEKC). As described above, the describe the relationship between y and x (lack of fit
regression lines were obtained by use of the least test) was assessed with F , 3.71 (P50.05) for allcalc
squares method following the hypothesis of homos- vitamins. Finally, the slopes and intercepts of the
cedasticity [27,28]. All regression lines were found regression lines for standards and spiked placebos,
to pass through the origin with t , 2.16 (P5 respectively, were found to be not significantlycalc
0.05). In all cases, the linearity of the calibration different, with t , 2.05 (P50.05) for each vita-calc
graphs was demonstrated by the high determination min. From the results of these statistical tests, it can
coefficients obtained for the regression lines and be concluded that in the operating conditions de-
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Table 4
CZE: linearity and accuracy (spiked placebos)





r 0.9990 0.9990 0.9994 0.9993 0.9992 0.9991
23Intercept (10 ) 0.4 27.5 0.9 20.2 28.8 0.3
23Slope (10 ) 1.6 1.3 2.0 1.2 0.3 0.2
Accuracy: mean recovery6C.I. (%)
Concentration levels (%)
50 100.461.9 100.260.7 99.661.7 101.360.8 99.661.0 100.662.9
100 99.76 1.0 99.861.6 101.161.9 100.061.1 99.961.3 101.160.9
150 99.860.4 100.060.6 99.661.3 99.860.9 100.660.8 99.461.2
Table 5
MEKC: linearity and accuracy (spiked placebos)





r 0.9993 0.9991 0.9993 0.9991 0.9992 0.9991
23Intercept (10 ) 1 4.8 1.6 0.04 20.9 0.4
23Slope (10 ) 1.5 1.2 2.1 1.1 0.3 0.1
Accuracy: mean recovery6C.I. (%)
Concentration levels (%)
50 101.362.0 100.962.4 99.862.0 100.562.4 100.760.8 99.062.8
100 99.661.0 99.861.4 99.761.5 100.761.0 99.461.2 101.061.8
150 100.261.1 100.060.3 99.760.6 99.661.4 99.561.6 99.161.5
scribed above, there is no matrix effect, even for significant differences between the results obtained
nicotinamide in CZE, which migrates with the with CZE and MEKC methods (Tables 4 and 5).
electroosmotic flow, and a single-level calibration
corresponding to the labelled amount of each vitamin 3.3.3. Accuracy
could be used in routine analysis. There are no Accuracy was assessed over the whole concen-
Table 6
CZE: precision (spiked placebos)
Concentration Thiamine Nicotinamide Riboflavin Pyridoxine Ascorbic Pantothenic
levels (%) acid acid
Repeatability (k53, n56, RSD %)
50 1.6 1.8 2.0 2.1 1.0 3.1
100 1.3 1.0 1.4 1.1 0.9 2.4
150 1.0 0.8 0.9 1.0 0.8 2.0
Intermediate precision (k53, n56, RSD %)
50 2.9 3.0 3.0 2.6 2.4 4.3
100 1.8 1.6 1.9 1.7 2.2 2.6
150 1.0 1.2 1.2 1.3 1.6 2.0
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Table 8tration range (50, 100 and 150%) by analysing
aDetermination of six vitamins in commercial preparationsplacebos spiked with the six vitamins at three
Sample Analyte Percent of the labelledconcentration levels (n56). Mean recoveries with
(labelled amount (average6SD)95% confidence intervals (C.I.) are given in Table 4
amounts, mg)(CZE) and Table 5 (MEKC). With both methods, CZE MEKC
bsatisfactory results with respect to accuracy were Tablet 1 B1 (4.2) 101.760.9 101.361.6
obtained for the six vitamins. The maximum ex- B2 (4.8) 96.962.4 97.161.6
B3 (54.0) 100.460.6 100.261.1perimental bias for each point is lower than 1.8%
B5 (18.0) 101.061.0 100.961.4which is an acceptable value for an active ingredient
B6 (6.0) 99.261.2 99.661.6in a pharmaceutical formulation. The two methods C (180.0) 98.660.7 99.260.9
can therefore be considered as accurate over the
range investigated. No significant differences were Tablet 2 B1 (1.2) 97.861.3 98.261.7
B2 (1.8) 95.461.9 96.162.3observed between the results obtained with CZE and
B3 (19.0) 99.260.7 98.961.3MEKC methods (Tables 4 and 5).
B5 (9.2) 98.661.3 98.461.9
B6 (2.2) 99.261.8 99.662.13.3.4. Precision C (100) 98.261.0 98.661.2
As can be seen in Table 6 (CZE) and Table 7
Tablet 3 B1 (195.2) 100.960.9 100.762.2(MEKC), precision was determined by measuring
B2 (10.0) 99.362.1 99.561.8repeatability and intermediate precision (between-
B6 (208.3) 100.261.6 100.261.4day precision) for each vitamin in spiked placebos
(n56). This study was carried out for 3 days (k53) Tablet 4 B1 (2.8) 98.461.1 98.161.4
at the same three concentration levels (50, 100 and B2 (3.2) 97.162.2 97.461.7
B3 (36.0) 100.660.8 100.961.1150%). The RSD values were estimated from re-
B5 (12.0) 98.761.7 98.661.4peatability and time-different intermediate precision
B6 (2.0) 97.861.8 97.562.2
variances, respectively [27,28]. Satisfactory results C (180.0) 101.461.2 101.660.9
with respect to precision were obtained for all
a CZE: Buffer: 50 mM borax adjusted to pH 8.5 with boric acid;vitamins studied.
rinsing sequence: buffer with 25 mM of SDS for 1 min and
running buffer for 1 min; no PN and I.S.; MEKC: Buffer: 50 mM
3.4. Quantitative analysis of vitamins in several borax adjusted to pH 8.5 with boric acid, containing 25 mM of
commercial multivitamin preparations SDS; rinsing sequence: running buffer for 2 min; no PN and I.S.;
other conditions as described in Section 2.
b CZE results are those presented in Table 3 (C).The water-soluble vitamins contained in four
Table 7
MEKC: precision (spiked placebos)
Concentration Thiamine Nicotinamide Riboflavin Pyridoxine Ascorbic Pantothenic
levels (%) acid acid
Repeatability (k53, n56, RSD %)
50 1.7 1.6 1.8 2.0 1.0 2.9
100 1.5 1.3 1.3 1.2 0.8 2.1
150 0.9 0.5 0.8 1.6 0.7 1.8
Intermediate precision (k53, n56, RSD %)
50 3.1 2.6 3.0 3.0 2.4 4.2
100 1.7 1.3 1.5 1.2 2.0 2.4
150 0.9 1.2 0.8 1.7 1.1 1.9
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